![]() ![]() High Risk: Indicates a higher than average chance that the baby has a chromosome abnormality.Low Risk: Indicates there is a lower than average chance that the fetus has one of the chromosome conditions that are being tested for. ![]() Results reports fall into three main categories: Results documentation includes the following. Click here to view the updated Panorama NIPT risk reporting We have updated the risk scores by incorporating the results from the Panorama algorithm and our clinical experience data to provide a Postive Predictive Value (high risk) or an Negative Predictive Value (low risk). The ordering physician will receive results by fax. LifeLabs Genetics will not share results directly with patients. While it is not the intent of the test, the baby’s sex information can also be identified using Panorama®. Microdeletion syndromes (e.g., Angelman, Cri du chat, DiGeorge, Prader Willi) No other prenatal screen currently exists for microdeletion syndromes, and the majority of microdeletions have no family history or obvious signs on prenatal ultrasounds.ĭetection rates are listed below: Condition Panorama® screens for the most common microdeletions, which occur collectively in 1 in 1000 pregnancies, and include 22q11.2 deletion syndrome (DiGeorge syndrome), 1p36 deletion syndrome, Angelman syndrome, Cri-du-chat syndrome, and Prader-Willi syndrome. Panorama® is also able to screen for other conditions that involve small pieces of missing genetic information, known as microdeletion syndromes. Panorama® does not screen for all possible birth defects and genetic diseases, such as open neural tube defects. Panorama® sequences only those chromosomes of interest (13, 18, 21, X, and Y), using single-nucleotide polymorphisms (SNPs) as markers of abnormality. Panorama® determines the likelihood that the fetus could be affected by chromosome abnormalities. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |